We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Trade Desk, Inc. (TTD - Free Report) is a provider of technology platform for advertising.Trade Desk is benefiting from the momentum in programmatic ad buying. Further, the emergence of digital content boosted the usage of this company’s inventory across all forms of ConnectedTV (“CTV”). Moreover, recovering ad demand and spending scenarios are expected to drive the top line. The Trade Desk currently flaunts a Zacks Rank of 1 and a Growth Score of A. The Zacks Consensus Estimate for this multi-billion dollar company’s 2020 earnings was recently revised upward by double digits. For 2021, the consensus mark for earnings has moved north by double digits also.Trade Desk is one company that helped the Nasdaq Achieve Record Highs this year. It has a market cap of more than $10 billion.Company shares are up by triple digits year to date.
Lennar Corporation (LEN - Free Report) is engaged in homebuilding and financial services in the United States. Lennar’s shares have outperformed its industry so far this year. The price performance was backed by solid housing market fundamentals. The company has been benefiting from higher demand for new homes, reflective of healthy housing market fundamentals arising from declining mortgage rates and a decline in inventory levels. Effective cost control and focus on making its homebuilding platform more efficient are resulting in higher operating leverage. Although rising land and labor costs remain headwinds, its focus on lighter land strategy to boost free cash flow will bolster the balance sheet and thereby drive returns. Earnings estimates moved upward over the past 60 days, reflecting analysts’ optimism over the company’s growth prospect.The company is using its dynamic pricing model, which enables it to set price according to the evolving market conditions. Courtesy of this strategy, Lennar has been taking advantage of the strong demand trend, which is helping it to maximize cash flow and return on inventory.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Top Stock Picks for Week of December 21, 2020
The Trade Desk, Inc. (TTD - Free Report) is a provider of technology platform for advertising.Trade Desk is benefiting from the momentum in programmatic ad buying. Further, the emergence of digital content boosted the usage of this company’s inventory across all forms of ConnectedTV (“CTV”). Moreover, recovering ad demand and spending scenarios are expected to drive the top line. The Trade Desk currently flaunts a Zacks Rank of 1 and a Growth Score of A. The Zacks Consensus Estimate for this multi-billion dollar company’s 2020 earnings was recently revised upward by double digits. For 2021, the consensus mark for earnings has moved north by double digits also.Trade Desk is one company that helped the Nasdaq Achieve Record Highs this year. It has a market cap of more than $10 billion.Company shares are up by triple digits year to date.
Lennar Corporation (LEN - Free Report) is engaged in homebuilding and financial services in the United States. Lennar’s shares have outperformed its industry so far this year. The price performance was backed by solid housing market fundamentals. The company has been benefiting from higher demand for new homes, reflective of healthy housing market fundamentals arising from declining mortgage rates and a decline in inventory levels. Effective cost control and focus on making its homebuilding platform more efficient are resulting in higher operating leverage. Although rising land and labor costs remain headwinds, its focus on lighter land strategy to boost free cash flow will bolster the balance sheet and thereby drive returns. Earnings estimates moved upward over the past 60 days, reflecting analysts’ optimism over the company’s growth prospect.The company is using its dynamic pricing model, which enables it to set price according to the evolving market conditions. Courtesy of this strategy, Lennar has been taking advantage of the strong demand trend, which is helping it to maximize cash flow and return on inventory.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>